1 completed, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow Ularitide: new trials by email Literature Review of Ularitide trials Research Report on Ularitide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Refractory Ascites in Patients With Liver Cirrhosis, and the Potential Treatment With 48 Hours Infusion of Ularitide. Ularitide, Placebo - Cirrhosis, Liver, Ascites Hepatic | Phase 2 | Terminated | University of Aarhus | 17 | 2020-08-01 | 2023-05-18 |
| Prevention Of Nephrotoxicity Following Bone Marrow Transplantation Using Urodilatin and Mannitol URODILATIN (ULARITIDE, ATRIAL NATRIURETIC PEPTIDE), MANNITOL - Renal Dysfunction, Acute Renal Failure | Phase 2 | Completed | Rocky Mountain Cancer Centers | 20 | 2003-07-01 | 2008-06-03 |
Acute Kidney Injury (1) · Ascites (1) · Fibrosis (1) · Liver Cirrhosis (1) · Renal Insufficiency (1)
Rocky Mountain Cancer Centers (1) · University of Aarhus (1)
Denmark (1) · United States (1)
2019 (1)